Mensana Pharma Ltd.
06000593
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 08/10/2025
Due 22/10/2026
Industry
Officers
director · Since 23/10/2022
DIRECTOR
BRITISH · ENGLAND · Age 68
Also on 89 other boards
Persons with Significant Control
Mr Molnar Lorant Janos
Hungarian · Serbia · Age 60
Elscot House, Arcadia Avenue, London, N3 2JU
Notified 06/04/2016
CompanyRankvs 470+ SIC 46460 peers71
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£463k
Balance sheet strength
Cash
£1.6M
Cash in the bank
Net Current Assets
£463k
Working capital
Current Assets
£2.6M
Current Liabilities
£2.1M
Debtors
£966k
Tax at Year End(2023)
Director Loans(2023)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 1.22 | +£104k |
| 2023 | 1.15 | +£115k |
| 2022 | 1.10 | +£16k |
| 2021 | 1.10 | — |
| 2020 | 1.09 | — |
| 2019 | 1.11 | — |
| 2018 | 1.15 | — |
Derived from filed accounts. Not audited figures.